Concepedia

Indirikumar Balasubramanian

IB

Statistics

Publications

1

Citations

35

H-Index

1

Active since

2012

Affiliations

National University Cancer Institute, Singapore(Current)

Indirikumar Balasubramanian is an author at National University Cancer Institute, Singapore specializing in pi3k inhibitors, cytotoxic chemotherapy, and drug combination therapy.

Publications per year

2012–2012

1

Publications

1

Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in<i>PIK3CA</i>mutant gastric cancer cells

Bhaskar Bhattacharya, Mohamed Akram, Indirikumar Balasubramanian et al. · Cancer Biology & Therapy · 2012 · 35 citations · Full text

, , +17

1–1 of 1